Supplementation with a fish protein hydrolysate (Micromesistius poutassou): Effects on body weight, body composition, and CCK/GLP-1 secretion

Food and Nutrition Research

Volumn 60, Issue , 2016, Pages

  Nobile, Vincenzo ^a   Duclos, Elisa ^b   Michelotti, Angela ^a   Bizzaro, Gioia ^a   Negro, Massimo ^c   Soisson, Florian ^b  

^a Farcoderm Srl Member of Complife Group   (Italy)

^b Compagnie des Pêches Saint Malo Santé ^*  (France)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Blue whiting; Body composition; Body weight; Cholecystokinin; Clinical study; Fish protein hydrolysate; Glucagon like peptide 1; Weight management

Indexed keywords

CHOLECYSTOKININ; FISH PROTEIN; GLUCAGON LIKE PEPTIDE 1;

ADULT; ARTICLE; BODY WEIGHT; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; EXTRACELLULAR FLUID; FAT MASS; FEMALE; FISH; GLUCAGON LIKE PEPTIDE 1 BLOOD LEVEL; HIP CIRCUMFERENCE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MICROMESISTIUS POUTASSOU; OBESITY; PROTEIN HYDROLYSIS; RANDOMIZED CONTROLLED TRIAL; THIGH CIRCUMFERENCE; WAIST CIRCUMFERENCE;

EID: 84958819038     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v60.29857     Document Type: Article

References (33)

1. Benjakul S, Yarnpakdee S, Senphan T, Halldorsdottir SM, Kristinsson HG. Fish protein hydrolysates: production, bioactivities and applications. In: Kristinsson HG, ed. Antioxidants and functional components in aquatic foods, 1st ed. Reykjavik, Iceland: Matil Ltd; 2014. pp. 237-83.
2. Moller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: indication for health effects. Eur J Nutr 2008;47: 171-82.
3. Hatanaka A, Miyahara H, Suzuki KI, Sato S. Isolation and identification of antihypertensive peptides from Antarctic krill tail meat hydrolysate. J Food Sci 2009;74: H116-20.
4. Kim SK, Ngo DH, Vo TS. Marine fish-derived bioactive peptides as potential antihypertensive agents. Adv Food Nutr Res 2012;65: 249-60.
5. Li Y, Zhou J, Huang K, Sun Y, Zeng X. Purification of a novel angiotensin I converting enzyme (ACE) inhibitory peptide with an antihypertensive effect from loach (Misgurnus anguillicaudatus). J Agric Food Chem 2012;60: 1320-5.
6. Ngo DH, Ryu B, Vo TS, Himaya SW, Wijesekara I, Kim SK. Free radical scavenging and angiotensin-I converting enzyme inhibitory peptides from Pacific cod (Gadus macrocephalus) skin gelatin. Int J Biol Macromol 2011;49: 1110-16.
7. Nazeer RA, Sampath Kumar NS, Jai Ganesh R. In vitro and in vivo studies on the antioxidant activity of fish peptide isolated from the croaker (Otolithes ruber) muscle protein hydrolysate. Peptides 2012;35: 261-8.
8. Najafian L, Babji AS. A review of fish-derived antioxidant and antimicrobial peptides: their production, assessment, and applications. Peptides 2012;33: 178-85.
9. Sampath Kumar NS, Nazeer RA, Jaiganesh R. Purification and identification of antioxidant peptides from the skin protein hydrolysate of two marine fishes, horse mackerel (Magalaspis cordyla) and croaker (Otolithes ruber). Amino Acids 2012;42: 1641-9.
10. Yang R, Wang J, Liu Z, Pei X, Han X, Li Y. Antioxidant effect of a marine oligopeptide preparation from chum salmon (Oncorhynchus keta) by enzymatic hydrolysis in radiation injured mice. Mar Drugs. 2011;9: 2304-15.
11. Duarte J, Vinderola G, Ritz B, Perdigon G,Matar C. Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation. Immunobiology 2006;211: 341-50.
12. Fitzgerald AJ, Rai PS, Marchbank T, Taylor GW, Ghosh S, Ritz BW, et al. Reparative properties of a commercial fish protein hydrolysate preparation. Gut 2005;54: 775-81.
13. Marchbank T, Limdi JK, Mahmood A, Elia G, Playford RJ. Clinical trial: protective effect of a commercial fish protein hydrolysate against indomethacin (NSAID)-induced small intestinal injury. Aliment Pharmacol Ther 2008;28: 799-804.
14. Rigamonti E, Parolini C, Marchesi M, Diani E, Brambilla S, Sirtori CR, et al. Hypolipidemic effect of dietary pea proteins: impact on genes regulating hepatic lipid metabolism. Mol Nutr Food Res 2010;54(Suppl 1): S24-30.
15. Sugiyama K, Ohkawa S, Muramatsu K. Relationship between amino acid composition of diet and plasma cholesterol level in growing rats fed a high cholesterol diet. J Nutr Sci Vitaminol (Tokyo) 1986;32: 413-23.
16. Shukla A, Bettzieche A, Hirche F, Brandsch C, Stangl GI, Eder K. Dietary fish protein alters blood lipid concentrations and hepatic genes involved in cholesterol homeostasis in the rat model. Br J Nutr 2006;96: 674-82.
17. Bjørndal B, Berge C, Ramsvik MS, Svardal A, Bohov P, Skorve J, et al. A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation. Lipids Health Dis 2013;12: 143.
18. Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006;55(12): 3387-93.
19. Hisadome K, Reimann F, Gribble FM, Trapp S. Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like peptide 1 neurons. Diabetes 2010;59: 1890-98.
20. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, et al. Chemical characterization of leptin-Activated neurons in the rat brain. J Comp Neurol 2000;423: 261-81.
21. Kopin A, Foulds MW, McBride EW, Nguyen M, Al-Haider W, Schmitz F, et al. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 1999;103: 383-91.
22. Scrocchi LA, Brown TJ, MaCluskyN, Brubaker PL,Auerbach AB, Joyner AL, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 1996;2(11): 1254-8.
23. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381(6581): 415-21.
24. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 1992;41: 1422-8.
25. World Health Organization (2015). Fact sheet 311-obesity and overweight. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/[cited 21 December 2015].
26. Cudennec B, Ravallec-Plé R, Courois E, Fouchereau-Peron M. Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells. Food Chem 2008;111(4): 970-5.
27. Cudennec B, Fouchereau-PeronM, Ferry F, Duclos E, Ravallec R. In vitro and in vivo evidence for a satiating effect of fish protein hydrolysate obtained from blue whiting (Micromesistius poutassou) muscle. J Func Foods 2012;4(1): 271-7.
28. Zär Y, Duclos E, Housez B, Vergara C, Cazaubiel M, Soisson F. Evaluation of the satiating properties of a fish protein hydrolysate among overweight women: a pilot study. Nutr Food Sci 2014;44(5): 389-99.
29. NIH Consensus Statement. Bioelectrical impedance analysis in body composition measurement: National Institute of Health Technology Assessment Conference Statement. December 12-14, 1994. Nutrition 1996; 12: 749-62.
30. National Health and Nutrition Examination Survey III (1998). Body measurements (anthropometry). Rockville, MD: Westat.
31. Pirke KM, Kellner MB, Friess E, Krieg JC, Fichter MM. Satiety and cholecystokinin. Int J Eat Disord 1994;15: 63-9.
32. TamaiH,Takemura J,KobayashiN,Matsubayashi S,Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993;42: 581-4.
33. Näslund E, Melin I, Grybäck P, Hägg A, Hellström PM, Jacobsson H, et al. Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr 1997;66: 26-32.